Computational Advances in Drug Safety: Systematic and Mapping Review of Knowledge Engineering Based Approaches
暂无分享,去创建一个
Vassilis Koutkias | Marie-Christine Jaulent | Cédric Bousquet | Pantelis Natsiavas | Andigoni Malousi | M. Jaulent | C. Bousquet | A. Malousi | V. Koutkias | P. Natsiavas
[1] Zhengwu Lu,et al. Information technology in pharmacovigilance: Benefits, challenges, and future directions from industry perspectives , 2009, Drug, healthcare and patient safety.
[2] Vineet Sangar,et al. Systems pharmacology modeling: an approach to improving drug safety. , 2014, Biopharmaceutics & drug disposition.
[3] Martin Boeker,et al. Evaluating the Good Ontology Design Guideline (GoodOD) with the Ontology Quality Requirements and Evaluation Method and Metrics (OQuaRE) , 2014, PloS one.
[4] Hongfang Liu,et al. Standardizing adverse drug event reporting data , 2014, J. Biomed. Semant..
[5] Christophe G. Lambert,et al. Bridging Islands of Information to Establish an Integrated Knowledge Base of Drugs and Health Outcomes of Interest , 2014, Drug Safety.
[6] Yan Zhu,et al. Ontology-based systematic representation and analysis of traditional Chinese drugs against rheumatism , 2017, BMC Systems Biology.
[7] Vassilis Koutkias,et al. OpenPVSignal: Advancing Information Search, Sharing and Reuse on Pharmacovigilance Signals via FAIR Principles and Semantic Web Technologies , 2018, Front. Pharmacol..
[8] G. Trifirò,et al. The economic burden of preventable adverse drug reactions: a systematic review of observational studies , 2018, Expert opinion on drug safety.
[9] Avner Schlessinger,et al. Systems Pharmacology: An Overview , 2016 .
[10] Theodore R Rieger,et al. Improving the generation and selection of virtual populations in quantitative systems pharmacology models. , 2018, Progress in biophysics and molecular biology.
[11] Marco Viceconti,et al. In silico clinical trials: concepts and early adoptions , 2019, Briefings Bioinform..
[12] Marie-Christine Jaulent,et al. OntoADR a semantic resource describing adverse drug reactions to support searching, coding, and information retrieval , 2016, J. Biomed. Informatics.
[13] G. Omenn,et al. Ontology-Based Combinatorial Comparative Analysis of Adverse Events Associated with Killed and Live Influenza Vaccines , 2012, PloS one.
[14] Y. He,et al. Differential Adverse Event Profiles Associated with BCG as a Preventive Tuberculosis Vaccine or Therapeutic Bladder Cancer Vaccine Identified by Comparative Ontology-Based VAERS and Literature Meta-Analysis , 2016, PloS one.
[15] A. Chan,et al. Research Techniques Made Simple: Assessing Risk of Bias in Systematic Reviews. , 2016, The Journal of investigative dermatology.
[16] Xiaowei Xu,et al. Mining FDA drug labels using an unsupervised learning technique - topic modeling , 2011, BMC Bioinformatics.
[17] Daniel M. Lowe,et al. Efficient chemical-disease identification and relationship extraction using Wikipedia to improve recall , 2016, Database J. Biol. Databases Curation.
[18] Maria Liakata,et al. Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness , 2013, J. Biomed. Semant..
[19] P Ryan,et al. Novel Data‐Mining Methodologies for Adverse Drug Event Discovery and Analysis , 2012, Clinical pharmacology and therapeutics.
[20] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[21] R. Sharan,et al. INDI: a computational framework for inferring drug interactions and their associated recommendations , 2012, Molecular systems biology.
[22] Bin Zhao,et al. The Ontology of Vaccine Adverse Events (OVAE) and its usage in representing and analyzing adverse events associated with US-licensed human vaccines , 2013, J. Biomed. Semant..
[23] Cui Tao,et al. Network-based analysis of vaccine-related associations reveals consistent knowledge with the vaccine ontology , 2013, J. Biomed. Semant..
[24] Nigam H. Shah,et al. Mining clinical text for signals of adverse drug-drug interactions , 2014, J. Am. Medical Informatics Assoc..
[25] Vassilis Koutkias,et al. A Multiagent System for Integrated Detection of Pharmacovigilance Signals , 2016, Journal of Medical Systems.
[26] Jing Liu,et al. An ensemble method for extracting adverse drug events from social media , 2016, Artif. Intell. Medicine.
[27] B. Hammond. Ontology , 2004, Lawrence Booth’s Book of Visions.
[28] Torgeir Dingsøyr,et al. Knowledge management in software engineering: A systematic review of studied concepts, findings and research methods used , 2008, Inf. Softw. Technol..
[29] Darrell R. Abernethy,et al. Linking MedDRA®-Coded Clinical Phenotypes to Biological Mechanisms by the Ontology of Adverse Events: A Pilot Study on Tyrosine Kinase Inhibitors , 2016, Drug Safety.
[30] Yongqun He,et al. Identification of fever and vaccine-associated gene interaction networks using ontology-based literature mining , 2012, J. Biomed. Semant..
[31] Y. He,et al. Ontology-Based Vaccine Adverse Event Representation and Analysis. , 2017, Advances in experimental medicine and biology.
[32] Mark Avigan,et al. Informatic Tools and Approaches in Postmarketing Pharmacovigilance Used by FDA , 2008, The AAPS Journal.
[33] Abeed Sarker,et al. Pharmacovigilance from social media: mining adverse drug reaction mentions using sequence labeling with word embedding cluster features , 2015, J. Am. Medical Informatics Assoc..
[34] Vivienne J. Zhu,et al. Feasibility and utility of applications of the common data model to multiple, disparate observational health databases , 2015, J. Am. Medical Informatics Assoc..
[35] A. Vallano,et al. Hospital Doctorsâ Views and Concerns about Pharmacovigilance , 2015 .
[36] V. Koutkias. From Data Silos to Standardized, Linked, and FAIR Data for Pharmacovigilance: Current Advances and Challenges with Observational Healthcare Data , 2019, Drug Safety.
[37] Chitta Baral,et al. Discovering drug–drug interactions: a text-mining and reasoning approach based on properties of drug metabolism , 2010, Bioinform..
[38] Alexandros Stamatakis,et al. PICS-Ord: unlimited coding of ambiguous regions by pairwise identity and cost scores ordination , 2011, BMC Bioinformatics.
[39] Krzysztof Wnuk,et al. Knowledge Management in Software Testing: A Systematic Snowball Literature Review , 2018, e Informatica Softw. Eng. J..
[40] Jing Zhao,et al. Ensembles of randomized trees using diverse distributed representations of clinical events , 2016, BMC Medical Informatics and Decision Making.
[41] Michelle Whirl-Carrillo,et al. Evidence and resources to implement pharmacogenetic knowledge for precision medicine. , 2016, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[42] John Fox,et al. A short account of Knowledge Engineering , 1984, The Knowledge Engineering Review.
[43] Anne Cocos,et al. Deep learning for pharmacovigilance: recurrent neural network architectures for labeling adverse drug reactions in Twitter posts , 2017, J. Am. Medical Informatics Assoc..
[44] Isabel Segura-Bedmar,et al. Conceptual models of drug-drug interactions: A summary of recent efforts , 2016, Knowl. Based Syst..
[45] D. Stanski,et al. Drug-disease modeling in the pharmaceutical industry - where mechanistic systems pharmacology and statistical pharmacometrics meet. , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[46] Patrice Degoulet,et al. Building an ontology of adverse drug reactions for automated signal generation in pharmacovigilance , 2006, Comput. Biol. Medicine.
[47] Vassilis Koutkias,et al. Large-scale adverse effects related to treatment evidence standardization (LAERTES): an open scalable system for linking pharmacovigilance evidence sources with clinical data , 2017, J. Biomed. Semant..
[48] A. Vallano,et al. Hospital Doctors’ Views and Concerns about Pharmacovigilance , 2015 .
[49] R. M. Mehta. The importance of pharmacovigilance , 2017 .
[50] Patrice Degoulet,et al. Implementation of automated signal generation in pharmacovigilance using a knowledge-based approach , 2005, Int. J. Medical Informatics.
[51] Ali Anil Sinaci,et al. An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies , 2016, BioMed research international.
[52] Marie-Christine Jaulent,et al. Formalizing MedDRA to support semantic reasoning on adverse drug reaction terms , 2014, J. Biomed. Informatics.
[53] William W. Stead,et al. Toward a science of learning systems: a research agenda for the high-functioning Learning Health System , 2014, J. Am. Medical Informatics Assoc..
[54] D. Altman,et al. Assessing Risk of Bias in Included Studies , 2008 .
[55] Miki Yokotsuka,et al. The use of a medical dictionary for regulatory activities terminology (MedDRA) in prescription-event monitoring in Japan (J-PEM) , 2000, Int. J. Medical Informatics.
[56] Natalia Grabar,et al. Semantic distance-based creation of clusters of pharmacovigilance terms and their evaluation , 2015, J. Biomed. Informatics.
[57] Zhongming Zhao,et al. Machine learning-based prediction of drug-drug interactions by integrating drug phenotypic, therapeutic, chemical, and genomic properties. , 2014, Journal of the American Medical Informatics Association : JAMIA.
[58] Ping Zhang,et al. Large-scale structural and textual similarity-based mining of knowledge graph to predict drug-drug interactions , 2017, J. Web Semant..
[59] Shiew-Mei Huang,et al. Role of Systems Modeling in Regulatory Drug Approval , 2016 .
[60] Michel Dumontier,et al. The SADI Personal Health Lens: A Web Browser-Based System for Identifying Personally Relevant Drug Interactions , 2013, JMIR research protocols.
[61] César de Pablo-Sánchez,et al. Resolving anaphoras for the extraction of drug-drug interactions in pharmacological documents , 2010, BMC Bioinformatics.
[62] Maryse Lapeyre-Mestre,et al. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. , 2011, British journal of clinical pharmacology.
[63] Jingcheng Du,et al. Extracting drug-enzyme relation from literature as evidence for drug drug interaction , 2016, J. Biomed. Semant..
[64] Michel Beigbeder,et al. Vigi4Med Scraper: A Framework for Web Forum Structured Data Extraction and Semantic Representation , 2017, PloS one.
[65] Cui Tao,et al. OAE: The Ontology of Adverse Events , 2014, J. Biomed. Semant..
[66] G Declerck,et al. Bridging Data Models and Terminologies to Support Adverse Drug Event Reporting Using EHR Data , 2014, Methods of Information in Medicine.
[67] Marie-Christine Jaulent,et al. Computational Approaches for Pharmacovigilance Signal Detection: Toward Integrated and Semantically-Enriched Frameworks , 2015, Drug Safety.
[68] Michael J. Keiser,et al. Systems pharmacology augments drug safety surveillance , 2014, Clinical pharmacology and therapeutics.
[69] Gang Wang,et al. SSEL-ADE: A semi-supervised ensemble learning framework for extracting adverse drug events from social media , 2017, Artif. Intell. Medicine.
[70] Tong Shu Li,et al. Combining machine learning, crowdsourcing and expert knowledge to detect chemical-induced diseases in text , 2016, Database J. Biol. Databases Curation.
[71] A. Venot,et al. Appraisal of the MedDRA Conceptual Structure for Describing and Grouping Adverse Drug Reactions , 2005, Drug safety.
[72] Alexander Zien,et al. Improving drug safety with a systems pharmacology approach. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[73] Dr.R.V.S.N.S Ramachandudu,et al. Importance of Pharmacovigilance , 2015 .
[74] Alan Ruttenberg,et al. The Logic of Surveillance Guidelines: An Analysis of Vaccine Adverse Event Reports from an Ontological Perspective , 2014, PloS one.
[75] Patrick B. Ryan,et al. Accuracy of an automated knowledge base for identifying drug adverse reactions , 2017, J. Biomed. Informatics.
[76] Luca Toldo,et al. Extraction of potential adverse drug events from medical case reports , 2012, Journal of biomedical semantics.
[77] Abeed Sarker,et al. Portable automatic text classification for adverse drug reaction detection via multi-corpus training , 2015, J. Biomed. Informatics.
[78] Quan Xu,et al. ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms , 2014, Nucleic Acids Res..
[79] G. Niklas Norén,et al. A Decade of Data Mining and Still Counting , 2010, Drug safety.
[80] Mary Regina Boland,et al. Systems biology approaches for identifying adverse drug reactions and elucidating their underlying biological mechanisms , 2016, Wiley interdisciplinary reviews. Systems biology and medicine.
[81] B D Athey,et al. Needs for an Expanded Ontology‐Based Classification of Adverse Drug Reactions and Related Mechanisms , 2012, Clinical pharmacology and therapeutics.
[82] Vassilis Koutkias,et al. Knowledge engineering for adverse drug event prevention: On the design and development of a uniform, contextualized and sustainable knowledge-based framework , 2012, J. Biomed. Informatics.
[83] Yu Lin,et al. The eXtensible ontology development (XOD) principles and tool implementation to support ontology interoperability , 2018, Journal of Biomedical Semantics.
[84] Rahul Singh,et al. Leveraging graph topology and semantic context for pharmacovigilance through twitter-streams , 2016, BMC Bioinformatics.
[85] W Ceusters,et al. An Evolutionary Approach to Realism-based Adverse Event Representations , 2010, Methods of Information in Medicine.
[86] Marie Lindquist,et al. The Need for Definitions in Pharmacovigilance , 2007, Drug safety.
[87] Ari Z. Klein,et al. Social media mining for birth defects research: A rule-based, bootstrapping approach to collecting data for rare health-related events on Twitter , 2018, J. Biomed. Informatics.
[88] Z. Bankowski,et al. Council for International Organizations of Medical Sciences , 1991 .
[89] Ryuzo Azuma,et al. Drug interaction prediction using ontology-driven hypothetical assertion framework for pathway generation followed by numerical simulation , 2008, BMC Bioinformatics.
[90] Robert Stevens,et al. MIRO: guidelines for minimum information for the reporting of an ontology , 2018, J. Biomed. Semant..
[91] Rebecca Racz,et al. Ontology-based collection, representation and analysis of drug-associated neuropathy adverse events , 2016, J. Biomed. Semant..
[92] Zina M. Ibrahim,et al. ADEPt, a semantically-enriched pipeline for extracting adverse drug events from free-text electronic health records , 2017, PloS one.
[93] Rong Xu,et al. A semi-supervised approach to extract pharmacogenomics-specific drug-gene pairs from biomedical literature for personalized medicine , 2013, J. Biomed. Informatics.
[94] Erik M. van Mulligen,et al. Knowledge-based extraction of adverse drug events from biomedical text , 2014, BMC Bioinformatics.
[95] Yu Lin,et al. Ontology representation and analysis of vaccine formulation and administration and their effects on vaccine immune responses , 2012, J. Biomed. Semant..
[96] T. Bürkle,et al. E‐pharmacovigilance: development and implementation of a computable knowledge base to identify adverse drug reactions , 2013, British journal of clinical pharmacology.
[97] Paloma Martínez,et al. A linguistic rule-based approach to extract drug-drug interactions from pharmacological documents , 2011, BMC Bioinformatics.
[98] D. Mager,et al. Systems Pharmacology and Pharmacodynamics , 2016, AAPS Advances in the Pharmaceutical Sciences Series.
[99] Saroja Ramanujan,et al. Quantitative Systems Pharmacology: Applications and Adoption in Drug Development , 2016 .
[100] Martin Krallinger,et al. LimTox: a web tool for applied text mining of adverse event and toxicity associations of compounds, drugs and genes , 2017, Nucleic Acids Res..
[101] Hongfei Lin,et al. Extracting Drug-Drug Interaction from the Biomedical Literature Using a Stacked Generalization-Based Approach , 2013, PloS one.
[102] Yen S. Low,et al. Text Mining for Adverse Drug Events: the Promise, Challenges, and State of the Art , 2014, Drug Safety.
[103] Yiannis Kompatsiaris,et al. Panacea, a semantic-enabled drug recommendations discovery framework , 2014, VDOS+DO@ICBO.
[104] Guus Schreiber. Knowledge Engineering , 2008, Handbook of Knowledge Representation.
[105] Hua Xu,et al. Identifying Plausible Adverse Drug Reactions Using Knowledge Extracted from the Literature , 2014, AMIA.
[106] Adeeb Noor,et al. Drug-drug interaction discovery and demystification using Semantic Web technologies , 2017, J. Am. Medical Informatics Assoc..
[107] Von-Wun Soo,et al. Analysis of adverse drug reactions using drug and drug target interactions and graph-based methods , 2010, Artif. Intell. Medicine.
[108] John Debenham,et al. Knowledge Engineering , 1998, Artificial Intelligence.
[109] Paloma Martínez,et al. DINTO: Using OWL Ontologies and SWRL Rules to Infer Drug-Drug Interactions and Their Mechanisms , 2015, J. Chem. Inf. Model..
[110] Zina M. Ibrahim,et al. Knowledge graph prediction of unknown adverse drug reactions and validation in electronic health records , 2017, Scientific Reports.
[111] J Bouaud,et al. Toward a Formalization of the Process to Select IMIA Yearbook Best Papers , 2014, Methods of Information in Medicine.
[112] Ian Horrocks,et al. Handbook of Knowledge Representation Edited Description Logics 3.1 Introduction , 2022 .
[113] Halil Kilicoglu,et al. Using semantic predications to uncover drug-drug interactions in clinical data , 2014, J. Biomed. Informatics.
[114] Asunción Gómez-Pérez,et al. The NeOn Methodology for Ontology Engineering , 2012, Ontology Engineering in a Networked World.
[115] Núria Queralt-Rosinach,et al. DisGeNET-RDF: harnessing the innovative power of the Semantic Web to explore the genetic basis of diseases , 2015, bioRxiv.
[116] Marie-Christine Jaulent,et al. A case report: using SNOMED CT for grouping Adverse Drug Reactions Terms , 2008, BMC Medical Informatics Decis. Mak..
[117] Shangbo Zhou,et al. Statistical and Ontological Analysis of Adverse Events Associated with Monovalent and Combination Vaccines against Hepatitis A and B Diseases , 2016, Scientific Reports.
[118] Trevor Cohen,et al. Embedding of semantic predications , 2017, J. Biomed. Informatics.
[119] Amanda Hicks,et al. Therapeutic indications and other use-case-driven updates in the drug ontology: anti-malarials, anti-hypertensives, opioid analgesics, and a large term request , 2017, J. Biomed. Semant..
[120] Rebecca Racz,et al. Updates on the web-based VIOLIN vaccine database and analysis system , 2013, Nucleic Acids Res..
[121] Paloma Martínez,et al. Simplifying drug package leaflets written in Spanish by using word embedding , 2017, Journal of Biomedical Semantics.
[122] Maria Kvist,et al. Identifying adverse drug event information in clinical notes with distributional semantic representations of context , 2015, J. Biomed. Informatics.
[123] Marie-Christine Jaulent,et al. Exploiting heterogeneous publicly available data sources for drug safety surveillance: computational framework and case studies , 2017, Expert opinion on drug safety.
[124] F. Collins,et al. A new initiative on precision medicine. , 2015, The New England journal of medicine.
[125] Núria Queralt-Rosinach,et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants , 2016, Nucleic Acids Res..
[126] Jerome T Mettetal,et al. Systems pharmacology to predict drug safety in drug development. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[127] Michel Dumontier,et al. Discovering associations between adverse drug events using pattern structures and ontologies , 2017, J. Biomed. Semant..
[128] Hsinchun Chen,et al. A research framework for pharmacovigilance in health social media: Identification and evaluation of patient adverse drug event reports , 2015, J. Biomed. Informatics.
[129] Kazuhiko Ohe,et al. A Querying Method over RDF-ized Health Level Seven v2.5 Messages Using Life Science Knowledge Resources , 2016, JMIR medical informatics.
[130] Halil Kilicoglu,et al. SemMedDB: a PubMed-scale repository of biomedical semantic predications , 2012, Bioinform..
[131] Yong Hu,et al. Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports , 2017, Artif. Intell. Medicine.
[132] Lu Lu,et al. Bioinformatics analysis of immune response to group A streptococcal sepsis integrating quantitative trait loci mapping with genome-wide expression studies , 2008, BMC Bioinformatics.
[133] Hongfang Liu,et al. Mining severe drug-drug interaction adverse events using Semantic Web technologies: a case study , 2015, BioData Mining.
[134] Liwei Wang,et al. Ontology-based systematical representation and drug class effect analysis of package insert-reported adverse events associated with cardiovascular drugs used in China , 2017, Scientific Reports.
[135] Yu Lin,et al. The ontology of genetic susceptibility factors (OGSF) and its application in modeling genetic susceptibility to vaccine adverse events , 2014, J. Biomed. Semant..
[136] Maria J Grant,et al. A typology of reviews: an analysis of 14 review types and associated methodologies. , 2009, Health information and libraries journal.
[137] Cui Tao,et al. Ontology-based time information representation of vaccine adverse events in VAERS for temporal analysis , 2012, J. Biomed. Semant..
[138] Yongqun He,et al. Ontology-Based Vaccine and Drug Adverse Event Representation and Theory-Guided Systematic Causal Network Analysis Toward Integrative Pharmacovigilance Research , 2016, Current Pharmacology Reports.
[139] Dinh Q. Phung,et al. Estimation of the prevalence of adverse drug reactions from social media , 2017, Int. J. Medical Informatics.
[140] Jie Shen,et al. Adverse Drug Events: Database Construction and in Silico Prediction , 2013, J. Chem. Inf. Model..
[141] J. Chen,et al. Predicting adverse side effects of drugs , 2011, BMC Genomics.
[142] Adrien Ugon,et al. Using visual analytics for presenting comparative information on new drugs , 2017, J. Biomed. Informatics.